The U2 snRNP particle is an essential component of the eukaryotic pre-mRNA splicing apparatus, the spliceosome. Natural and semisynthetic inhibitors that bind the SF3b subunit of the U2 snRNP block splicing and prompt nuclear export of intron-bearing precursors, defining a new mode of action in anticancer drugs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kotake, Y. et al. Nat. Chem. Biol. 3 570–575 (2007).
Kaida, D. et al. Nat. Chem. Biol. 3 576–583 (2007).
Burge, C.B., Tuschl, T. & Sharp, P.A. in The RNA World (eds. Gesteland, R.F., Cech, T.R. & Atkins, J.F.) 525–560 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, USA, 1999).
Jurica, M.S. & Moore, M.J. Mol. Cell 12, 5–14 (2003).
Will, C.L. et al. EMBO J. 21, 4978–4988 (2002).
Tanackovic, G. & Kramer, A. Mol. Biol. Cell 16, 1366–1377 (2005).
O'Keefe, R.T., Mayeda, A., Sadowski, C.L., Krainer, A.R. & Spector, D.L. J. Cell Biol. 124, 249–260 (1994).
Casolari, J.M. & Silver, P.A. Trends Cell Biol. 14, 222–225 (2004).
Wang, Q., He, J., Lynn, B. & Rymond, B.C. Mol. Cell. Biol. 25, 10745–10754 (2005).
Dziembowski, A. et al. EMBO J. 23, 4847–4856 (2004).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Rymond, B. Targeting the spliceosome. Nat Chem Biol 3, 533–535 (2007). https://doi.org/10.1038/nchembio0907-533
Issue Date:
DOI: https://doi.org/10.1038/nchembio0907-533
This article is cited by
-
Optimization of a Bioluminescence Resonance Energy Transfer-Based Assay for Screening of Trypanosoma cruzi Protein/Protein Interaction Inhibitors
Molecular Biotechnology (2018)
-
Expanding rare disease drug trials based on shared molecular etiology
Nature Biotechnology (2014)
-
Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis
Leukemia (2013)
-
Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders
Leukemia (2012)
